- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01040949
En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking (Parejas)
Smoking among Latino males living in the U.S. is a significant public health problem, one that can contribute to disparities in life expectancy and increase mortality. Latinos smoke at the same rate as White males but are less likely than Whites to quit. Interventions do not reach Latino smokers because many speak only Spanish and previous interventions have had notable limitations. First, most have recruited volunteers, so hard-to-reach Latino smokers likely did not participate. Second, cessation effects were short-term only. Third, no program has attempted to boost Latino cessation rates by capitalizing on a "teachable moment", a time when quitting may seem especially relevant. To address these deficits, we propose to conduct a teachable moment intervention trial for Latino smokers. We will attempt to capitalize on the potential teachable moment of Latinas' pregnancy as an impetus for Latinos' cessation. We will include couples, rather than just men, to sustain intervention effects. We will partner with community leaders to develop an intervention based primarily on Social Cognitive Theory, the Teachable Moment Model, and the Cognitive-Behavioral Couple Therapy Model. Some elements will be at the individual level to help Latinos quit smoking and others will be couple-based to improve communication and reduce stress in the postpartum relationship. The program will be culturally sensitive to Latino values, such as familismo, valuing of and duty to the family and personalismo, valuing warm personal relationships. We will recruit Latino couples (n=366) into a Guia (control) arm in which men receive a culturally appropriate smoking cessation guide, and a couple-based smoking cessation counseling arm.
Hypothesis 1: Latino expectant fathers who receive couple-based counseling to quit smoking will be more likely to be abstinent from smoking at 28 weeks in pregnancy and 12 months post-randomization than Latino expectant fathers who receive a self-help smoking cessation guide.
Hypothesis 2: Couple-based counseling will improve mediators, such as couple communication about smoking, self-efficacy, outcome expectancies, stress levels, risk perceptions, emotion, and self-image, which in turn, will increase cessation rates among Latino expectant fathers.
Hypothesis 3: Couples in the counseling arm will have a greater increase in cessation during pregnancy and a lower decrease in cessation at 6 and 12 months post-randomization than couples in the Guia arm.
Study Overview
Status
Conditions
Detailed Description
BACKGROUND & SIGNIFICANCE Latino men are just as likely to smoke as non-Hispanic White men; [CDC, 2004] however, few smoking cessation programs have shown long term effects among Latinos. Further, many Latinos cannot enter traditional smoking cessation programs because they do not speak English. To be effective, programs should capitalize on a "teachable moment". [McBride, 2003] Pregnancy has been shown to be a teachable moment for women to quit smoking; whether it is a teachable moment for partners has not been explored. Including Latinas and intervening with the couple might help sustain cessation effects long term. The aim of this randomized controlled trial is to compare a culturally tailored intervention to a minimal intervention (self-help smoking cessation guides or Guia) in promoting and sustaining smoking cessation among expectant Latino fathers during pregnancy and postpartum.
DESIGN & PROCEDURES
When describing this study to the pregnant women, we will explain that half of the couples will be randomly assigned to receive face-to-face counseling plus a self-help cessation guide (Guia) while the other half will receive the self-help smoking cessation guide only. When a woman agrees to have us meet with her and her husband/partner, we will send her home with two consent forms, one for her and one for her husband/partner, along with a small gift for the upcoming baby. We also will set up a time and place to meet the couple for their initial data assessment. We will not collect information about legal status of patients.
Couples who are randomized to the face-to-face support intervention will be asked to attend two two-hour in-home sessions, one in pregnancy and one after the baby is born. Each man and each woman will receive four booster calls, two in pregnancy and two post-partum. These calls last approximately ten minutes. At the individual level, the intervention focuses on skills training for behavior change (smoking cessation for men and diet or exercise for women) and goal setting. At the couple level, the intervention focuses on skills training for communication (speaking and listening skills and problem solving).
Sample size considerations A total of 366 couples will be randomized to the two arms within strata defined by whether this is their first pregnancy. The primary objectives are to test whether there are arm differences in the proportion of fathers who are abstinent from smoking at 28 weeks of pregnancy (time 1) and at 12 months post-randomization (time 2). We expect attrition rates among fathers of 20% and 30% at time 1 and time 2, respectively; dropouts will be imputed to be non-abstinent in an intention-to-treat analysis. The chi-square test for a difference in two proportions will be used to test the null hypotheses of no difference in abstinence rates between the two arms. The overall one-sided alpha level will be controlled at 0.025 by conducting each test at a one-sided alpha of 0.0125. Based on Nevid and colleagues' previous study that compared counseling to pamphlets,[Nevid, 1997] we anticipate abstinence rates of 10% and 5% in the Guia only arm at time 1 and time 2, respectively. The alternative hypotheses are that the arm difference at time 1 will be 15% (25% versus 10%) and at time 2 will be 10% (15% versus 5%). A sample of size 366 was selected to have at least 90% power for each alternative hypothesis. For the effect at time 2 to have 90% power, the effect at time 1 is overpowered at 97%. It is assumed that the arm effects of 25% versus 10% at time 1 and of 15% versus 5% at time 2 consider those participants who dropout and have their outcomes imputed to be non-abstinent. Thus, under the alternative hypotheses, the probabilities of response among just those 80% and 70% who do not drop out are (31% versus 13%) and (21% versus 7%), respectively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female: 18 or older (or 16 years or older if legally married), not smoking, married or living with a partner who smokes, and less than 25 weeks pregnant (to allow enough time to intervene during pregnancy).
- Male: 18 or older (or 16 years or greater if legally married, living with the woman, smoked in past 30 days, and plans to live in the area for at least two years.
Exclusion Criteria:
- Female: currently smoking.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: a self help smoking cessation guide
Guia, a culturally relevant self-help smoking cessation guide in Spanish
|
A culturally sensitive smoking cessation self help program for Latinos
|
|
Experimental: couple-based counseling for smoking cessation plus Guia
couple-based counseling for smoking cessation plus Guis, culturally relevant self-help smoking cessation guide for Latinos
|
Culturally sensitive couple-based counseling for smoking cessation plus self-help smoking cessation guide in Latino men with pregnant partners
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
seven-day point prevalence smoking abstinence
Time Frame: 28 weeks gestation and 12 months post-randomization
|
28 weeks gestation and 12 months post-randomization
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
continued abstinence (no smoking at all in between and including all follow-ups)
Time Frame: 28 weeks gestation, 6 and 12 months post-randomization
|
28 weeks gestation, 6 and 12 months post-randomization
|
|
prolonged abstinence (continued abstinence after two week grace period with failures counting as smoking seven days in a row or one day in two consecutive weeks)
Time Frame: 28 weeks gestation, 6 and 12 months post-randomization
|
28 weeks gestation, 6 and 12 months post-randomization
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00008540
- 1R01CA127307-01A2 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Guia -a self help smoking cessation guide
-
University of OklahomaNational Cancer Institute (NCI); H. Lee Moffitt Cancer Center and Research... and other collaboratorsNot yet recruiting
-
The University of Hong KongNot yet recruiting
-
Beijing Normal UniversityNot yet recruitingSmoking Cessation | Mobile HealthChina
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; South London and Maudsley NHS Foundation...CompletedAnxiety | Autism Spectrum DisordersUnited Kingdom
-
Beijing Normal UniversityRecruiting
-
Alba González-Roz, PhDDelegación del Gobierno para el Plan Nacional sobre DrogasRecruiting
-
The University of Hong KongHong Kong Council on Smoking and HealthCompleted
-
The University of Hong KongActive, not recruiting
-
University of Southern DenmarkDanish Cancer Society; National Board of Health, DenmarkUnknownSmoking | Smoking Cessation | Self-efficacyDenmark